Shanghai Sharing technologies Co., Ltd.

Shanghai Sharing technologies Co., Ltd.

Country: China (Mainland)Business Type: Other

Manufacturer

qq

Products Categories
Contact US
Ms.Zhang
Tel: 86-021-66787223
  • Fax: 86-021-51861772
  • Province/state: Shanghai
  • City: Shanghai
  • Street:No11, Lane 225, Jinxiang Road,Pudong district
  • MaxCard:
Home > Products > 

3α-Hydroxy-7-keto-5β-cholanic Acid

3α-Hydroxy-7-keto-5β-cholanic Acid CAS NO.4651-67-6

  • FOB Price: USD: 3,300.00-5,000.00 /Kilogram Get Latest Price
  • Min.Order: 100 Gram
  • Payment Terms: L/C,D/A,D/P,T/T,
  • Available Specifications:

    grade 1(1-10)Kilogramgrade 1(50-100)Kilogram

  • Product Details

Keywords

  • 6-Ethylchnodeoxycholic acid intermediates
  • 4651-67-6
  • Obeticholic acid intermediates

Quick Details

  • ProName: 3α-Hydroxy-7-keto-5β-cholanic Acid
  • CasNo: 4651-67-6
  • Molecular Formula: C24H38O4
  • Appearance: white crystalline powder
  • Application: Obeticholic acid intermediates 4651-...
  • DeliveryTime: on stock
  • PackAge: 25kg/bag
  • Port: shanghai
  • ProductionCapacity: 100 Kilogram/Month
  • Purity: 98.0%
  • Storage: room temperature, well-sealed
  • Transportation: common goods, common shipment
  • LimitNum: 100 Gram
  • Moisture Content: 0.5%
  • Impurity: 1.0%max
  • purity: 98.0%

Superiority

we are the first company to approach the Obeticholic acid  project at the moment.

3α-Hydroxy-7-keto-5β-cholanic Acid is the key intermediates of Obeticholic acid.

 

Guaranteed & Quality control:

1. COA & MSDS.

2. Pre-sample is available on request!

3. Good service, Our chemist always available to discuss your demand.

your good business partner with SHARING TECH.

 

 

Details

It is know as INT-747. It is undergoing development as a pharmaceuitcal agent for several liver diseases and reated disorders.

Active Indication: Liver disease; Primary sclerosing cholangitis; Alcoholic hepatitis; Primary biliary
cirrhosis; Diarrhea; Portal hypertension; Non-alcoholic steatohepatitis

Inactive Indications:Jaundice;Non alcoholic fatty liver disease

Farnesoid X receptor agonist

Other Actions: Anti-inflammatory; Bile acid modulator

Technologies: Oral formulation; Small molecule therapeutic

Other products of this supplier